{"id":7791,"date":"2025-10-30T09:20:52","date_gmt":"2025-10-30T09:20:52","guid":{"rendered":"https:\/\/www.viamedsalud.com\/ivoqa\/?p=7791"},"modified":"2025-10-30T09:20:54","modified_gmt":"2025-10-30T09:20:54","slug":"world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment","status":"publish","type":"post","link":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/","title":{"rendered":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment"},"content":{"rendered":"<p>Every October, and especially on October 30, medical and patient associations launch awareness campaigns about <strong>liver cancer<\/strong>. Their goal is to highlight the importance of <strong>early diagnosis and prevention<\/strong>, promote <strong>hepatitis B vaccination<\/strong>, <strong>hepatitis C treatment<\/strong>, and the <strong>control of fatty liver disease<\/strong> and <strong>alcohol consumption<\/strong>.<\/p>\n<p>At <strong>IVOQA<\/strong>, we join this commitment by promoting medical check-ups, <strong>screening programs for high-risk patients<\/strong>, and <strong>access to the most innovative treatments<\/strong>. Our <strong>Tumor Board<\/strong> includes specialists in both <strong>primary and metastatic liver cancer<\/strong>, as well as <strong>surgeons specialized in minimally invasive liver surgery<\/strong> and <strong>interventional radiologists<\/strong> highly experienced in <strong>liver tumor and metastasis ablation<\/strong>.<\/p>\n<p><strong>Liver cancer<\/strong> remains one of the leading causes of cancer-related mortality worldwide. Its management requires a <strong>multidisciplinary and updated approach<\/strong> that integrates prevention, early detection, and the latest therapeutic innovations.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>What Is Liver Cancer?<\/strong><\/h2>\n<p>The term refers to the <strong>uncontrolled growth of malignant cells<\/strong> within the liver. It is important to distinguish between <strong>primary liver cancer<\/strong> and <strong>liver metastases<\/strong>.<\/p>\n<h2><strong>Types:<\/strong><\/h2>\n<ul>\n<li><strong>Primary liver cancer:<\/strong> when the tumor originates within the liver itself. The most common forms are:\n<ul>\n<li><strong>Hepatocellular carcinoma (HCC):<\/strong> accounts for 80\u201390% of cases, usually developing in livers affected by <strong>cirrhosis<\/strong> or <strong>chronic hepatitis<\/strong>.<\/li>\n<li><strong>Intrahepatic cholangiocarcinoma:<\/strong> a less common cancer that arises from the <strong>bile ducts inside the liver<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Liver metastases:<\/strong> tumors that spread to the liver from other organs (colon, breast, lung, among others). Their treatment depends on the <strong>primary tumor type<\/strong>.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><strong>Common Risk Factors<\/strong><\/h2>\n<p>Liver cancer often develops in a <strong>previously diseased liver<\/strong>. The main risk factors include:<\/p>\n<ul>\n<li><strong>Chronic hepatitis B and C infections<\/strong>, still responsible for a large proportion of global cases.<\/li>\n<li><strong>Cirrhosis<\/strong> from any cause.<\/li>\n<li><strong>Excessive alcohol consumption.<\/strong><\/li>\n<li><strong>Non-alcoholic fatty liver disease (NAFLD\/NASH):<\/strong> increasingly common due to the obesity and metabolic syndrome epidemic.<\/li>\n<\/ul>\n<p><strong>Preventing and managing these conditions<\/strong> is essential to reduce liver cancer incidence.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Life Expectancy in Liver Cancer Patients<\/strong><\/h2>\n<p>Survival depends on several factors, including <strong>tumor stage at diagnosis<\/strong>, <strong>liver function<\/strong>, and the <strong>treatment received<\/strong>.<\/p>\n<h3><strong>For patients with hepatocellular carcinoma (HCC):<\/strong><\/h3>\n<ul>\n<li><strong>Early diagnosis:<\/strong> when the tumor is small and liver function is preserved, <strong>curative options<\/strong> (surgery, transplantation, ablation) can achieve <strong>5-year survival rates of 50\u201370%<\/strong> in selected patients.<\/li>\n<li><strong>Advanced disease:<\/strong> prognosis is more limited, although in recent years, <strong>systemic therapies<\/strong> have significantly improved median survival.<\/li>\n<\/ul>\n<p><strong>According to the treatment received:<\/strong><\/p>\n<ul>\n<li><strong>Surgery<\/strong> (including <strong>minimally invasive laparoscopic<\/strong> and <strong>robotic liver surgery<\/strong>) and <strong>liver transplantation<\/strong> offer the best chances of cure when feasible. Transplantation is now indicated not only for <strong>primary liver tumors<\/strong> but also for <strong>colon cancer liver metastases<\/strong> in selected cases.<\/li>\n<li><strong>Locoregional therapies:<\/strong> such as <strong>radiofrequency ablation (RFA)<\/strong>. In 2025, a landmark clinical trial reported that <strong>ablation for liver metastases from colon cancer achieves equivalent oncological outcomes to surgery<\/strong>, offering a <strong>minimally invasive alternative<\/strong> for eligible patients. Other treatments include <strong>chemoembolization<\/strong>, used when surgery is not possible, to reduce tumor size and number.<\/li>\n<li><strong>New systemic therapies:<\/strong> combinations of <strong>immunotherapy<\/strong> and <strong>targeted drugs<\/strong> have transformed advanced disease management.<\/li>\n<\/ul>\n<p>The integration of all these therapeutic approaches has marked a <strong>paradigm shift<\/strong>, improving both <strong>survival<\/strong> and <strong>quality of life<\/strong> in advanced-stage patients.<\/p>\n<p>&nbsp;<\/p>\n<h2><strong>For patients with liver metastases from colon cancer:<\/strong><\/h2>\n<p><strong>Without treatment:<\/strong><\/p>\n<ul>\n<li>Median survival: <strong>5\u201320 months<\/strong><\/li>\n<li>5-year survival: <strong>Extremely rare<\/strong><\/li>\n<\/ul>\n<p><strong>With treatment:<\/strong><\/p>\n<p><strong>Surgery (resection or ablation):<\/strong> offers the best chance of cure.<\/p>\n<ul>\n<li>5-year survival: <strong>24\u201358%<\/strong><\/li>\n<\/ul>\n<p><strong>Systemic chemotherapy without surgery:<\/strong><\/p>\n<ul>\n<li>5-year survival: <strong>Below 10%<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2><strong>Advances in Liver Cancer Research<\/strong><\/h2>\n<p>Recent years have brought significant advances in <strong>clinical research<\/strong>, especially for <strong>hepatocellular carcinoma (HCC)<\/strong>.<\/p>\n<p><strong>Immunotherapy<\/strong> has been a major breakthrough. Combinations such as <strong>atezolizumab + bevacizumab<\/strong> <a href=\"https:\/\/medically.roche.com\/content\/dam\/pdmahub\/restricted\/oncology\/esmo-2021\/ESMO-2021-poster-kudo-IMbrave150-exploratory-efficacy-and-safety-results-in-patients-with-hepatocellular-carcinoma.pdf\">(IMbrave150 trial<\/a>) and <strong>tremelimumab + durvalumab<\/strong> (<a href=\"https:\/\/ascopost.com\/issues\/october-10-2024\/himalaya-5-year-analysis-confirms-survival-benefit-of-stride-regimen-in-hepatocellular-carcinoma\/\">HIMALAYA trial<\/a>v) have shown <strong>significant overall survival benefits<\/strong> compared to standard treatments like <strong>sorafenib<\/strong>.<\/p>\n<p>More recently, the <strong><a href=\"https:\/\/ascopost.com\/issues\/december-10-2024-supplement-conference-highlights-esmo-2024\/leap-012-combination-of-therapies-extends-progression-free-survival-in-intermediate-stage-hepatocellular-carcinoma\/\">LEAP-012 trial<\/a><\/strong> represented the <strong>first major advance in 20 years<\/strong> for patients with <strong>intermediate-stage HCC<\/strong>. The combination of <strong>lenvatinib + pembrolizumab + chemoembolization<\/strong> achieved a <strong>progression-free survival of 14.6 months<\/strong>, compared to <strong>10 months<\/strong> with standard treatment, and an <strong>overall response rate of 72%<\/strong>. This study marks a <strong>new paradigm<\/strong> in managing these patients.<\/p>\n<p>Furthermore, at the <strong><a href=\"https:\/\/www.clinicbarcelona.org\/noticias\/nuevas-guias-europeas-para-mejorar-el-tratamiento-del-carcinoma-hepatocelular\">Liver Cancer Summit 2025<\/a><\/strong>, the <strong>EASL<\/strong> presented <strong>new European guidelines<\/strong> incorporating <strong>multiparametric decision models<\/strong>, <strong>LI-RADS criteria<\/strong>, and <strong>combined therapeutic strategies<\/strong>, strengthening the <strong>personalized and multidisciplinary approach<\/strong> to HCC management.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<div style=\"max-width: 800px; margin: 2em auto; font-family: Segoe UI, Arial, sans-serif;\">\n<h2 style=\"font-size: 1.8em; color: #005b99; font-weight: 600;\">Frequently Asked Questions about Liver Cancer<\/h2>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em; margin-bottom: 1.5em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">What is liver cancer and what are its main types?<\/div>\n<div style=\"color: #444; font-size: 1em;\">Liver cancer can be primary (hepatocellular carcinoma, cholangiocarcinoma) or secondary (metastases from other organs).<\/div>\n<\/div>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em; margin-bottom: 1.5em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">What are the most common symptoms?<\/div>\n<div style=\"color: #444; font-size: 1em;\">In the early stages, it may not cause any symptoms. When present, symptoms can include weight loss, abdominal pain, jaundice, ascites, cholangitis, elevated liver enzymes, or fatigue.<\/div>\n<\/div>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em; margin-bottom: 1.5em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">What factors increase the risk?<\/div>\n<div style=\"color: #444; font-size: 1em;\">Chronic hepatitis B and C, cirrhosis, alcohol consumption, fatty liver disease, obesity, and exposure to toxins such as aflatoxins.<\/div>\n<\/div>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em; margin-bottom: 1.5em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">How is it diagnosed?<\/div>\n<div style=\"color: #444; font-size: 1em;\">Through imaging tests (ultrasound, CT scan, MRI), tumor markers (AFP, CEA), and in some cases, a biopsy.<\/div>\n<\/div>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em; margin-bottom: 1.5em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">What is the life expectancy?<\/div>\n<div style=\"color: #444; font-size: 1em;\">It varies depending on the tumor type, stage, and treatment. For early-stage hepatocellular carcinoma treated with curative intent, 5-year survival rates can exceed 50%. In advanced disease, prognosis depends on the response to systemic therapies. For patients with liver metastases from colon cancer, treated in a multidisciplinary setting with chemotherapy and ablation or surgery, 5-year survival can reach up to 58%.<\/div>\n<\/div>\n<div style=\"border-left: 4px solid #005b99; padding-left: 1em;\">\n<div style=\"font-weight: 600; font-size: 1.2em; color: #005b99;\">What treatments are currently available?<\/div>\n<div style=\"color: #444; font-size: 1em;\">Surgery, liver transplantation, locoregional therapies, and systemic treatments such as immunotherapy and targeted drugs.<\/div>\n<\/div>\n<\/div>\n<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is liver cancer and what are its main types?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Liver cancer can be primary (hepatocellular carcinoma, cholangiocarcinoma) or secondary (metastases from other organs).\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What are the most common symptoms?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"In the early stages, it may not cause any symptoms. When present, symptoms can include weight loss, abdominal pain, jaundice, ascites, cholangitis, elevated liver enzymes, or fatigue.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What factors increase the risk?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Chronic hepatitis B and C, cirrhosis, alcohol consumption, fatty liver disease, obesity, and exposure to toxins such as aflatoxins.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How is it diagnosed?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Through imaging tests (ultrasound, CT scan, MRI), tumor markers (AFP, CEA), and in some cases, a biopsy.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is the life expectancy?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"It varies depending on the tumor type, stage, and treatment. For early-stage hepatocellular carcinoma treated with curative intent, 5-year survival rates can exceed 50%. In advanced disease, prognosis depends on the response to systemic therapies. For patients with liver metastases from colon cancer, treated in a multidisciplinary setting with chemotherapy and ablation or surgery, 5-year survival can reach up to 58%.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What treatments are currently available?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Surgery, liver transplantation, locoregional therapies, and systemic treatments such as immunotherapy and targeted drugs.\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Every October, and especially on October 30, medical and patient associations launch awareness campaigns about liver cancer. Their goal is to highlight the importance of early diagnosis and prevention, promote hepatitis B vaccination, hepatitis C treatment, and the control of fatty liver disease and alcohol consumption. At IVOQA, we join this commitment by promoting medical [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7794,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":["post-7791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-liver-cancer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA\" \/>\n<meta property=\"og:description\" content=\"Every October, and especially on October 30, medical and patient associations launch awareness campaigns about liver cancer. Their goal is to highlight the importance of early diagnosis and prevention, promote hepatitis B vaccination, hepatitis C treatment, and the control of fatty liver disease and alcohol consumption. At IVOQA, we join this commitment by promoting medical [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"IVOQA\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-30T09:20:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-30T09:20:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"viadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"viadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/\"},\"author\":{\"name\":\"viadmin\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/person\\\/4c39b59ca8db0f2e7fe6cf0323bd17d4\"},\"headline\":\"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment\",\"datePublished\":\"2025-10-30T09:20:52+00:00\",\"dateModified\":\"2025-10-30T09:20:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/\"},\"wordCount\":881,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Dia-mundial-cancer-de-higado.webp\",\"articleSection\":[\"Liver cancer\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/\",\"name\":\"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Dia-mundial-cancer-de-higado.webp\",\"datePublished\":\"2025-10-30T09:20:52+00:00\",\"dateModified\":\"2025-10-30T09:20:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Dia-mundial-cancer-de-higado.webp\",\"contentUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Dia-mundial-cancer-de-higado.webp\",\"width\":1536,\"height\":1024,\"caption\":\"Ilustraci\u00f3n minimalista del D\u00eda Mundial del C\u00e1ncer de H\u00edgado, con un h\u00edgado estilizado en tonos azul y turquesa sobre fondo estrellado, acompa\u00f1ada del texto \u2018D\u00eda Mundial del C\u00e1ncer de H\u00edgado \u2013 World Liver Cancer Day \u2013 30 de octubre\u2019, en referencia a la jornada de concienciaci\u00f3n sobre la prevenci\u00f3n y diagn\u00f3stico precoz del c\u00e1ncer hep\u00e1tico\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"IVOQA\",\"item\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diseases\",\"item\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Liver cancer\",\"item\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/disease\\\/liver-cancer\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\",\"name\":\"IVOQA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\"},\"alternateName\":\"Instituto Viamed de Oncolog\u00eda Quir\u00fargica Avanzada\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#organization\",\"name\":\"IVOQA\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/cropped-Recurso-3.png\",\"contentUrl\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/cropped-Recurso-3.png\",\"width\":896,\"height\":256,\"caption\":\"IVOQA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\\\/en\\\/#\\\/schema\\\/person\\\/4c39b59ca8db0f2e7fe6cf0323bd17d4\",\"name\":\"viadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g\",\"caption\":\"viadmin\"},\"sameAs\":[\"https:\\\/\\\/www.viamedsalud.com\\\/ivoqa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/","og_locale":"en_US","og_type":"article","og_title":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA","og_description":"Every October, and especially on October 30, medical and patient associations launch awareness campaigns about liver cancer. Their goal is to highlight the importance of early diagnosis and prevention, promote hepatitis B vaccination, hepatitis C treatment, and the control of fatty liver disease and alcohol consumption. At IVOQA, we join this commitment by promoting medical [&hellip;]","og_url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/","og_site_name":"IVOQA","article_published_time":"2025-10-30T09:20:52+00:00","article_modified_time":"2025-10-30T09:20:54+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp","type":"image\/webp"}],"author":"viadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"viadmin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#article","isPartOf":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/"},"author":{"name":"viadmin","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/person\/4c39b59ca8db0f2e7fe6cf0323bd17d4"},"headline":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment","datePublished":"2025-10-30T09:20:52+00:00","dateModified":"2025-10-30T09:20:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/"},"wordCount":881,"commentCount":0,"publisher":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp","articleSection":["Liver cancer"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/","name":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment - IVOQA","isPartOf":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#primaryimage"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp","datePublished":"2025-10-30T09:20:52+00:00","dateModified":"2025-10-30T09:20:54+00:00","breadcrumb":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#primaryimage","url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp","contentUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2025\/10\/Dia-mundial-cancer-de-higado.webp","width":1536,"height":1024,"caption":"Ilustraci\u00f3n minimalista del D\u00eda Mundial del C\u00e1ncer de H\u00edgado, con un h\u00edgado estilizado en tonos azul y turquesa sobre fondo estrellado, acompa\u00f1ada del texto \u2018D\u00eda Mundial del C\u00e1ncer de H\u00edgado \u2013 World Liver Cancer Day \u2013 30 de octubre\u2019, en referencia a la jornada de concienciaci\u00f3n sobre la prevenci\u00f3n y diagn\u00f3stico precoz del c\u00e1ncer hep\u00e1tico"},{"@type":"BreadcrumbList","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/world-liver-cancer-day-life-expectancy-prognostic-factors-and-advances-in-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"IVOQA","item":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/"},{"@type":"ListItem","position":2,"name":"Diseases","item":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/"},{"@type":"ListItem","position":3,"name":"Liver cancer","item":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/disease\/liver-cancer\/"},{"@type":"ListItem","position":4,"name":"World Liver Cancer Day: life expectancy, prognostic factors, and advances in treatment"}]},{"@type":"WebSite","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#website","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/","name":"IVOQA","description":"","publisher":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization"},"alternateName":"Instituto Viamed de Oncolog\u00eda Quir\u00fargica Avanzada","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#organization","name":"IVOQA","url":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2022\/09\/cropped-Recurso-3.png","contentUrl":"https:\/\/www.viamedsalud.com\/ivoqa\/wp-content\/uploads\/2022\/09\/cropped-Recurso-3.png","width":896,"height":256,"caption":"IVOQA"},"image":{"@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/#\/schema\/person\/4c39b59ca8db0f2e7fe6cf0323bd17d4","name":"viadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c513cde02c979a038b11704e7862fb9ea67e4a7877470796b4068ad2e51097a1?s=96&d=mm&r=g","caption":"viadmin"},"sameAs":["https:\/\/www.viamedsalud.com\/ivoqa"]}]}},"_links":{"self":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/7791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/comments?post=7791"}],"version-history":[{"count":2,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/7791\/revisions"}],"predecessor-version":[{"id":7796,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/posts\/7791\/revisions\/7796"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/media\/7794"}],"wp:attachment":[{"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/media?parent=7791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/categories?post=7791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.viamedsalud.com\/ivoqa\/en\/wp-json\/wp\/v2\/tags?post=7791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}